drugset / Trial / NCT01939990

Safety Study of Nebivolol for COPD Patients

NCT01939990

RandomizedParallel-groupDouble-blindHealth-services research

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start
2012-01
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nebivolol Other / unclassified 5 mg
Comparator Nebivolol Other / unclassified 10 mg

Indications